TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 4 | 10 | 9 | -9 | -24 | 10 | 0 |
| S | %wins | 0 | 0 | 0 | 100 | 100 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/8/10 20:48 | 3/4/10 | MAPP | Map Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Perseus Soros Partners LLC | NY | T | S.m | -74 | 13.98 | 3 | -5 | 0 | 2,826 | I | 10 | 593 | 52 | 54 | -5 | -4 | 3 | -5 | 4 | 10 | 9 | -9 | -24 | 10 | |
12/23/04 12:35 | 12/22/04 | BIVN | Bioenvision Inc | DE | Health | Drug | Pharmaceutical Preparations | Perseus Soros Partners LLC | DC | TH | See Foot | S | -131 | 8.55 | 0 | -15 | -2 | 765 | I | ||||||||||||||
12/23/04 11:47 | 12/21/04 | BIVN | Bioenvision Inc | DE | Health | Drug | Pharmaceutical Preparations | Perseus Soros Partners LLC | DC | TH | See Foot | S | -353 | 8.43 | 0 | -42 | -5 | 801 | I | ||||||||||||||
12/21/04 20:01 | 12/20/04 | BIVN | Bioenvision Inc | DE | Health | Drug | Pharmaceutical Preparations | Perseus Soros Partners LLC | DC | TH | See Foot | S | -93 | 8.59 | 0 | -11 | -1 | 875 | I | ||||||||||||||
12/21/04 19:59 | 12/17/04 | BIVN | Bioenvision Inc | DE | Health | Drug | Pharmaceutical Preparations | Perseus Soros Partners LLC | DC | TH | See Foot | S | -1,295 | 148.65 | 0 | -9 | -1 | 894 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |